KEGG   COMPOUND: C00123
Entry
C00123                      Compound                               
Name
L-Leucine;
2-Amino-4-methylvaleric acid;
(2S)-alpha-2-Amino-4-methylvaleric acid;
(2S)-alpha-Leucine
Formula
C6H13NO2
Exact mass
131.0946
Mol weight
131.17
Structure
Remark
Same as: D00030
Reaction
R01088 R01089 R01090 R01091 R02552 R03657 R08411 R08664
R10944
Pathway
map00280  Valine, leucine and isoleucine degradation
map00290  Valine, leucine and isoleucine biosynthesis
map00966  Glucosinolate biosynthesis
map00970  Aminoacyl-tRNA biosynthesis
map01060  Biosynthesis of plant secondary metabolites
map01065  Biosynthesis of alkaloids derived from histidine and purine
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map01210  2-Oxocarboxylic acid metabolism
map01230  Biosynthesis of amino acids
map02010  ABC transporters
map04150  mTOR signaling pathway
map04974  Protein digestion and absorption
map04978  Mineral absorption
map05131  Shigellosis
map05230  Central carbon metabolism in cancer
Module
M00036  Leucine degradation, leucine => acetoacetate + acetyl-CoA
Network
nt06024  Valine, leucine and isoleucine degradation
Enzyme
1.4.1.9         1.14.13.-       2.3.1.66        2.6.1.6         
2.6.1.42        2.6.1.67        3.5.1.64        5.4.3.7         
6.1.1.4         6.3.2.47
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00123  Leucine (Leu)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   L-Leucine
    D00030  Leucine (USP)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00030  L-Leucine
Other DBs
CAS: 61-90-5
PubChem: 3423
ChEBI: 15603
KNApSAcK: C00001377
PDB-CCD: LEU[PDBj]
NIKKAJI: J1.167C
LinkDB
KCF data

ATOM        9
            1   C1c C    25.0761  -19.4138
            2   C1b C    26.2633  -18.6769
            3   C6a C    23.8420  -18.7586
            4   N1a N    25.1229  -20.8173
            5   C1c C    27.4974  -19.3377
            6   O6a O    22.6841  -19.5483
            7   O6a O    23.8654  -17.3551
            8   C1a C    28.6846  -18.6007
            9   C1a C    27.5442  -20.7356
BOND        8
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     3   6 1
            6     3   7 2
            7     5   8 1
            8     5   9 1

» Japanese version

KEGG   COMPOUND: C00183
Entry
C00183                      Compound                               
Name
L-Valine;
2-Amino-3-methylbutyric acid
Formula
C5H11NO2
Exact mass
117.0790
Mol weight
117.15
Structure
Remark
Same as: D00039
Reaction
R01212 R01214 R01215 R01434 R01437 R02200 R03665 R04870
R08663 R10031 R10941 R10942
Pathway
map00280  Valine, leucine and isoleucine degradation
map00290  Valine, leucine and isoleucine biosynthesis
map00311  Penicillin and cephalosporin biosynthesis
map00460  Cyanoamino acid metabolism
map00770  Pantothenate and CoA biosynthesis
map00966  Glucosinolate biosynthesis
map00970  Aminoacyl-tRNA biosynthesis
map01060  Biosynthesis of plant secondary metabolites
map01063  Biosynthesis of alkaloids derived from shikimate pathway
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map01210  2-Oxocarboxylic acid metabolism
map01230  Biosynthesis of amino acids
map01240  Biosynthesis of cofactors
map02010  ABC transporters
map04974  Protein digestion and absorption
map04978  Mineral absorption
map05230  Central carbon metabolism in cancer
Module
M00019  Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine
M00119  Pantothenate biosynthesis, valine/L-aspartate => pantothenate
M00672  Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin
M00673  Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C
Network
nt06024  Valine, leucine and isoleucine degradation
Enzyme
1.4.1.8         1.4.1.9         1.4.1.23        1.14.14.38      
1.14.14.39      2.6.1.6         2.6.1.32        2.6.1.42        
2.6.1.66        4.1.1.14        6.1.1.9         6.3.2.26        
6.3.2.47
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00183  Valine (Val)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   L-Valine
    D00039  Valine (USP)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00039  L-Valine
Other DBs
CAS: 72-18-4
PubChem: 3483
ChEBI: 16414
KNApSAcK: C00001398
PDB-CCD: VAL[PDBj]
NIKKAJI: J9.179K
LinkDB
KCF data

ATOM        8
            1   C1c C    24.8500  -19.0764
            2   C1c C    26.0666  -18.3804
            3   C6a C    23.6334  -18.3629
            4   N1a N    24.8442  -20.4802
            5   C1a C    27.2716  -19.0881
            6   C1a C    26.0725  -16.9825
            7   O6a O    22.4226  -19.0589
            8   O6a O    23.6392  -16.9707
BOND        7
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 2

» Japanese version

KEGG   COMPOUND: C00407
Entry
C00407                      Compound                               
Name
L-Isoleucine;
2-Amino-3-methylvaleric acid
Formula
C6H13NO2
Exact mass
131.0946
Mol weight
131.17
Structure
Remark
Same as: D00065
Reaction
R02196 R02197 R02199 R02200 R03656 R06726 R09344 R09403
R10027 R10723 R10943 R11078 R11723 R12650
Pathway
map00280  Valine, leucine and isoleucine degradation
map00290  Valine, leucine and isoleucine biosynthesis
map00460  Cyanoamino acid metabolism
map00960  Tropane, piperidine and pyridine alkaloid biosynthesis
map00966  Glucosinolate biosynthesis
map00970  Aminoacyl-tRNA biosynthesis
map01060  Biosynthesis of plant secondary metabolites
map01064  Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map01210  2-Oxocarboxylic acid metabolism
map01230  Biosynthesis of amino acids
map02010  ABC transporters
map04974  Protein digestion and absorption
map04978  Mineral absorption
map05131  Shigellosis
map05230  Central carbon metabolism in cancer
Module
M00019  Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine
M00570  Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine
Network
nt06024  Valine, leucine and isoleucine degradation
Enzyme
1.4.1.9         1.4.3.2         1.14.11.45      1.14.11.74      
1.14.14.38      1.14.14.39      2.6.1.32        2.6.1.42        
5.1.1.21        6.1.1.5         6.3.2.47        6.3.2.50
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00407  Isoleucine (Ile)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   L-Isoleucine
    D00065  Isoleucine (USP)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00065  L-Isoleucine
Other DBs
CAS: 73-32-5
PubChem: 3697
ChEBI: 17191
KNApSAcK: C00001374
PDB-CCD: ILE[PDBj]
NIKKAJI: J2.818E
LinkDB
KCF data

ATOM        9
            1   C1c C    22.4922  -17.1397
            2   C1c C    23.6796  -16.4029
            3   C6a C    21.2581  -16.4789
            4   N1a N    22.5391  -18.5377
            5   C1b C    24.9137  -17.0637
            6   C1a C    23.6387  -15.0049
            7   O6a O    20.1001  -17.2742
            8   O6a O    21.2815  -15.0809
            9   C1a C    26.1069  -16.3268
BOND        8
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     2   6 1 #Up
            6     3   7 1
            7     3   8 2
            8     5   9 1

» Japanese version

DBGET integrated database retrieval system